INOVIO’s DNA Medicine INO-3107 Receives U.K. Innovation Passport
PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) announced that its lead DNA medicine candidate, INO-3107, has been granted an Innovation Passport by the U.K.’s Innovative Licensing and Access Pathway (ILAP). …
INOVIO’s DNA Medicine INO-3107 Receives U.K. Innovation Passport Read More